Kinney Horn
Corporate Officer/Principal bei IMMUNOME, INC.
Vermögen: 27 825 $ am 31.03.2024
Profil
Mr. Kinney Horn is a Chief Business Officer at Immunome, Inc. Mr. Horn was previously employed as a Chief Business Officer by Olema Pharmaceuticals, Inc. and a Director-Business Development by Genentech, Inc. He received his undergraduate degree from the University of Mary Washington and a graduate degree from Georgetown University.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 01.02.2023 | 2 458 ( 0,00% ) | 27 825 $ | 31.03.2024 |
Aktive Positionen von Kinney Horn
| Unternehmen | Position | Beginn |
|---|---|---|
| IMMUNOME, INC. | Corporate Officer/Principal | 01.02.2024 |
Ehemalige bekannte Positionen von Kinney Horn
| Unternehmen | Position | Ende |
|---|---|---|
| OLEMA PHARMACEUTICALS, INC. | Corporate Officer/Principal | 24.03.2023 |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Corporate Officer/Principal | 01.04.2019 |
Ausbildung von Kinney Horn
| Georgetown University | Graduate Degree |
| University of Mary Washington | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| IMMUNOME, INC. | Health Technology |
| OLEMA PHARMACEUTICALS, INC. | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Health Technology |
